Evidence map›Paper›PMID 40600046›Full record

ArticleFrontiers in medicine2025

AlzheimerViT: harnessing lightweight vision transformer architecture for proactive Alzheimer's screening.

C Kishor Kumar Reddy, Hafsa Ihteshamuddin Ahmed, Muhammad Mohzary, T Monika Singh, Mohammed Shuaib, Shadab Alam, Hani Mohammed Alnami

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

C Kishor Kumar ReddyDepartment of Computer Science and Engineering, Stanley College of Engineering and Technology for Women, Hyderabad, India.
Hafsa Ihteshamuddin AhmedDepartment of Computer Science and Engineering, Stanley College of Engineering and Technology for Women, Hyderabad, India.
Muhammad MohzaryDepartment of Computer Science, College of Engineering and Computer Science, Jazan University, Jazan, Saudi Arabia.
T Monika SinghDepartment of Computer Science and Engineering, Stanley College of Engineering and Technology for Women, Hyderabad, India.
Mohammed ShuaibDepartment of Computer Science, College of Engineering and Computer Science, Jazan University, Jazan, Saudi Arabia.
Shadab AlamDepartment of Computer Science, College of Engineering and Computer Science, Jazan University, Jazan, Saudi Arabia.
Hani Mohammed AlnamiDepartment of Computer Science, College of Engineering and Computer Science, Jazan University, Jazan, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Alzheimer's is a disease in the human brain characterized by gradual memory loss, confusion, and alterations in behavior. It is a complex and continuously degenerative disorder of the nervous system, which still has early detection and diagnosis as challenges to overcome. The disease causes significant damage in individuals suffering from the disorder as they progressively lose cognitive ability. Its diagnosis and management depend primarily on the ability to diagnose early to initiate proper intervention. Unfortunately, this remains a difficult feat, given the resemblance of early signs of the disease with symptoms associated with normal aging and other disorders involving cognition. While clinical tests have their limitations, brain imaging such as MRI can provide detailed insights into changes in the brain. Deep learning techniques, mainly when applied to MRI data, have proven helpful in the early detection of Alzheimer's Disease. Methods: In the proposed study, a lightweight, self-attention-based vision transformer (ViT) is employed to predict Alzheimer's disease using MRI images from the OASIS-3 dataset. Data pre-processing and augmentation techniques have been added to strengthen the model's generalization ability and enhance model performance, which is visualized using Grad-Cam. Results: The proposed model achieves exceptional results with an accuracy of 98.57%, approximate precision of 98.7%, Recall of about 98.47%, and specificity of 98.67%. It also achieves a Kappa Score of 97.2% and an AUC ROC Score of 99%. Conclusion: This paper, along with comprehensive data pre-processing and augmentation, represents one of the major steps toward achieving more robust and clinically applicable models for Alzheimer's disease prediction. The proposed study indicates that deep learning models have the potential to enhance the diagnosis of Alzheimer's disease. By integrating Deep learning techniques with careful data processing, more reliable early detection models can be developed, which in turn leads to better treatment outcomes.

Indexed as

Alzheimer’s diseasedata augmentationdeep learningdisease detectionMobileViT

Identifiers

PMID40600046
PMCPMC12210019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.